GLP-1 drugs are indicated for patients with BMI above 25 even without complications, or BMI above 23 with obesity-related conditions such as diabetes, hypertension, or fatty liver disease
Genetic predisposition data can inform this conversation by highlighting individual pathways that may be more or less responsive to specific peptide therapies, though genetics alone never determines treatment choice
In vitro studies revealed that AOD9604 enhances the differentiation of adipose-derived mesenchymal stem cells into bone, stimulates the production of proteoglycans and collagen in chondrocytes, and promotes myoblast differentiation into muscle cells
Factors like age, hormonal status, existing medical conditions, and concurrent medications all influence both the likelihood and severity of GLP-1 related dry mouth
We wondered whether, absent these enhancements, standard thiols might still react with H 2 O 2 at a meaningful rate, at least on a minute time scale at micromolar H 2 O 2